期刊文献+

影响原发性输尿管癌预后及其术后继发膀胱癌的多因素分析 被引量:4

Multifactor analysis of prognosis and the incidence of secondary bladder cancer in patients with primary ureteral carcinoma
下载PDF
导出
摘要 目的:探讨影响原发性输尿管癌预后及其术后继发膀胱癌的危险因素。方法:回顾性分析58例2010年6月至2017年9月于重庆医科大学附属第一医院行手术治疗,病理诊断为输尿管癌患者的临床资料,对可能影响输尿管癌预后的7个临床及病理因素进行单因素和多因素Cox模型分析,对可能影响输尿管癌术后继发膀胱癌的5个临床及病理因素进行单因素和多因素Cox模型分析。结果:单因素分析表明:临床分期(χ2=16.441,P=0.000)、组织学分级(χ2=6.941,P=0.008)、术后是否化疗(χ2=4.934,P=0.026)与输尿管癌预后显著相关。性别(χ2=0.414,P=0.520)、年龄(χ2=2.013,P=0.156)、肿瘤是否多发(χ2=0.029,P=0.865)、手术方式(χ2=0.243,P=0.622)与预后无关。浸润深度(χ2=5.314,P=0.021)、术后膀胱灌注(χ2=3.919,P=0.048)、组织学分级(χ2=7.025,P=0.008)、手术方式(χ2=6.565,P=0.010)与输尿管癌术后继发膀胱癌显著相关。肿瘤是否多发(χ2=1.291,P=0.256)与输尿管癌术后继发膀胱癌无关。多因素分析表明:临床分期(RR=6.037,95%CI=1.708~21.333,P=0.005)及组织学分级(RR=10.032,95%CI=1.161~86.695,P=0.036)是影响输尿管癌预后的显著因素,高级别组织学分级(RR=8.942,95%CI=1.175~68.056,P=0.034)及非根治手术(RR=3.819,95%CI=1.424~10.244,P=0.008)是输尿管癌术后继发膀胱癌的危险因素(RR>1)。结论:输尿管癌的临床分期及组织学分级是决定预后的显著影响因素;组织学分级及手术方式是影响输尿管癌术后继发膀胱癌的显著独立危险因素。 Objective:To discuss the risk factors which influence prognosis and the incidence of secondary bladder cancer in patients with primary ureteral carcinoma. Methods:The clinical data of 58 patients were retrospectively analyzed. All patients were pathologically diagnosed with primary ureteral carcinoma in the First Affiliated Hospital of Chongqing Medical University from June,2010 to September,2017 and then treated by operation. Clinical and pathological factors,seven on prognosis and five on the incidence of secondary bladder cancer,were collected and analyzed with univariate analysis and multivariate analysis respectively. Results:Univariate analysis identified three factors that were associated with prognosis:clinical stage(χ^2=16.441,P=0.000),histological grade of tumor(χ^2=6.941,P=0.008),chemotherapy or not(χ^2=4.934,P=0.026). But age(χ^2=2.013,P=0.156),gender(χ^2=0.414,P=0.520),method of operation(χ^2=6.565,P=0.010)and multifocal or unifocal tumor(χ^2=0.128,P=0.720)showed no significant influence on prognosis. The depth of invasion(χ^2=5.314,P=0.021),bladder irrigation after operation(χ^2=3.919,P=0.048),histological grade of tumor(χ^2=7.025,P=0.008)and method of operation(χ^2=6.565,P=0.010)were significantly associated with the incidence of secondary bladder cancer. But multifocal or unifocal tumor(χ^2=0.336,P=0.562)had no statistical significance on the incidence of secondary bladder cancer. Multi-variate analysis identified the significant factors for prognosis of ureteral cancer were clinical stage(RR=6.037,95%CI=1.708 to21.333,P=0.005)and histological grade of tumor(RR=10.032,95%CI=1.161 to 86.695,P=0.036). The influencing factors on the incidence of secondary bladder cancer were high grade histological of tumor(RR=8.942,95%CI=1.175 to 68.056,P=0.034)and non radical operation(RR=3.819,95%CI=1.424 to 10.244,P=0.008). Conclusion:The significant factors for prognosis of ureteral cancer are clinical stage and histological grade of tumor. The significant influencing factors on the incidence of secondary bladder cancer after ureteral cancer are the method of operation and histological grade of tumor.
作者 胡益仙 姜凡 陈宸 蒲军 Hu Yixian;Jiang Fan;Chen Chen;Pu Jun(Department of Urology,The First Affiliated Hospital of Chongqing Medical University)
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2019年第2期204-208,共5页 Journal of Chongqing Medical University
关键词 输尿管癌 预后 继发膀胱癌 COX比例风险回归模型 ureter carcinoma prognosis secondary bladder cancer Cox proportional hazard regression model
  • 相关文献

参考文献1

二级参考文献24

  • 1张争,潘柏年.原发性输尿管癌影响预后因素分析[J].中华泌尿外科杂志,2004,25(12):838-840. 被引量:19
  • 2Chen W,Zheng R, Baade PD, et al. Cancer statistics in China,2015[ J]. CA Cancer J Clin,2016,66( 1 ) :115 - 132.
  • 3Mcsut R, Shahrokh S, Wilhelm H, et al. Upper urinary tract urothelial carcinoma:whathave we learned in the last 4years[J].TherAdvUrol,2011,3(2):69-80.
  • 4Margulis V, Shariat SF, Matin SF, et al. Outcomes of radi- cal nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration[J].Cancer, 2009,115(6) :1224 - 1233.
  • 5Moch H,Humphrey PA,Ulbright TM, et al. WHO classi- fication of tumours of the urinary system and male genital organ [ M ]. Lyon:International Agency for Research on Cancer (IARC) ,2016:78 - 131.
  • 6Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer Staging Manual [ M]. 7th ed. New York : Springer ,2010:497 - 504.
  • 7Seitz C, Gupta A, Shariat S, et al. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international valida- tion study [ J ]. J Urol,2010,184 ( 5 ) : 1895 - 1900.
  • 8Zigeuner R, Shariat S, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract [ J ]. Eur Urol,2010,57(4) :575 -581.
  • 9Roupret M, Babjuk M, Compe rat E, et al. European guidelines on upper tract urothelial carcinomas:2013 up- date[J]. Eur Uro,2013,63(6) :1059 -1071.
  • 10Kirkali Z, Tuzel E. Transitional cell carcinoma of the ure- ter and renal pelvis[ J ]. Crit Rev Oncol Hematol,2003, 47(2) :155 - 169.

共引文献3

同被引文献44

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部